Last updated on May 2017

The BWEL Breast Cancer Weight Loss Study. Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (ALLIANCE A011401)


Brief description of study

The BWEL Breast Cancer Weight Loss Study. Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (ALLIANCE A011401)

Detailed Study Description

The BWEL Breast Cancer Weight Loss Study will look at whether losing weight, by eating less and exercising more, changes the risk of cancer recurrence in women who have been diagnosed with early breast cancer. The study will enroll more than 3,000 patients with breast cancer in the United States and Canada.

Clinical Study Identifier: TX149689

Contact Investigators or Research Sites near you

Start Over

Stephanie Cason

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »